Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06789406 · ClinicalTrials.gov registry record · NA
PMCF Study of the Axonics SNM System Model 5101 (R20)
A NA study of Overactive Bladder (OAB) and Urinary Urge Incontinence (UUI), sponsored by Axonics.
- Recruiting
- Registry status
- NA
- Development phase
- 55
- Enrollment target
- 4
- Study locations
NCT06789406 is a NA study of Overactive Bladder (OAB) and Urinary Urge Incontinence (UUI) that is actively recruiting participants, run by Axonics. The registered enrollment target is 55 participants, below the 284-participant average among 7 other Overactive Bladder (OAB) trials with a reported enrollment target (81% lower). The trial reports 4 study locations across 3 states.
The verdict
NCT06789406, a NA study of Overactive Bladder (OAB) and Urinary Urge Incontinence (UUI), is actively recruiting participants, sponsored by Axonics.
- RECRUITING
- Registry status
- NA
- Development phase
- 55 participants
- Enrollment target
- 4
- Study locations
Study Summary
Post-market clinical follow-up for continued assessment of safety and performance to confirm long-term outcomes of the Axonics SNM System INS Model 5101.
Conditions Studied
Interventions
- DEVICE Axonics SNM System INS Model 5101 (R20)
Study Locations (4)
West Yorkshire
- Bradford Royal Infirmary - Bradford
- Pinderfields Hospital - Wakefield
Illinois
- University of Chicago - Chicago
Other
- University College London Hospital - London
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2025-09-18 |
| Est. Completion | 2031-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06789406
The ClinicalTrials.gov registry entry for NCT06789406 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 284-participant average among 7 other Overactive Bladder (OAB) trials with a reported enrollment target (81% lower). The listed sponsor is Axonics, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Overactive Bladder (OAB) appearing as the primary indexed condition, and to 1 intervention - of which Axonics SNM System INS Model 5101 (R20) is the first listed.
NCT06789406 reports 4 study locations spanning 3 distinct geographic areas - top geographies include West Yorkshire, Illinois, Other.
Frequently Asked Questions
What is clinical trial NCT06789406 about?
NCT06789406 is a clinical study titled "PMCF Study of the Axonics SNM System Model 5101 (R20)". Post-market clinical follow-up for continued assessment of safety and performance to confirm long-term outcomes of the Axonics SNM System INS Model 5101.
What is the current status of trial NCT06789406?
This trial is currently recruiting. It is a NA study. The enrollment target is 55 participants. The study started on 2025-09-18. Estimated completion is 2031-10.
What conditions does trial NCT06789406 study?
This clinical trial studies the following conditions: Overactive Bladder (OAB), Urinary Urge Incontinence (UUI), Urinary Frequency (UF).
What interventions are being tested in trial NCT06789406?
The interventions under investigation include: Axonics SNM System INS Model 5101 (R20) (DEVICE).
Who is sponsoring clinical trial NCT06789406?
This trial is sponsored by Axonics, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06789406 being conducted?
This trial has 4 study locations across Illinois, West Yorkshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Overactive Bladder (OAB)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluating Pumpkin Seed Oil Extract Supplementation on Bladder Function
RECRUITING · NA
-
Detrusor Nerve Radiofrequency Ablation for Overactive Bladder in Women
RECRUITING · NA
-
Evaluation of a Non-Implanted Electrical Stimulation Device for Overactive Bladder (OAB)
RECRUITING · NA
-
APPROVE Trial: Evaluating a Prescription Digital Therapeutic for Treatment of OAB in Women
RECRUITING · NA
-
Zinc Supplementation With Botulinum Toxin for Overactive Bladder
RECRUITING · Phase 2
-
Assessing the Genitourinary Microbiome of Women With Overactive Bladder Undergoing Onabotulinum Toxin Type A Intradetrusor Injections
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.